What is NDC 70771-1951?

70771-1951 is the product NDC for Rivastigmine, Rivastigmine 13.3 mg/24h patch, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivastigmine?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivastigmine NDC 70771-1951 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1951Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1951Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1951-7	7077119510770771195107	30 POUCH in 1 CARTON (70771-1951-7) / 24 h in 1 POUCH (70771-1951-1)Marketed from Mar 6, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivastigmine
Generic name (nonproprietary): rivastigmine
Active ingredients: Rivastigmine — 13.3 mg/24h
Dosage form: Patch, Extended release
Route: Transdermal
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206318
Marketing start: Mar 6, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 70771-1951_eb52b342-1672-42e7-bb4c-9c8f1bce7fc3SPL ID eb52b342-1672-42e7-bb4c-9c8f1bce7fc3SPL set ID 966d59ea-5cea-4fef-8b96-e0efe885caf4RxCUI 725021, 725023, 1308569UNII PKI06M3IW0
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771195107 followed by a unit qualifier and the quantity

Package 70771-1951-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 17, 2025.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1951

What is NDC 70771-1951?: 70771-1951 is the product NDC for Rivastigmine, Rivastigmine 13.3 mg/24h patch, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivastigmine.
What is the active ingredient?: Rivastigmine.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivastigmine?: 16 other product NDCs are listed under this name. See all Rivastigmine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivastigmine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Northstar Rx LLC.	16714-116	16714-0116-02
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Northstar Rx LLC.	16714-117	16714-0117-02
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1196	70710-1196-07
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1197	70710-1197-07
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1198	70710-1198-07
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1949	70771-1949-07
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1950	70771-1950-07
Rivastigmine	Rivastigmine 4.6 mg/24h	PatchTransdermal	Mylan Pharmaceuticals Inc.	0378-9070	00378-9070-93
Rivastigmine	Rivastigmine 9.5 mg/24h	PatchTransdermal	Mylan Pharmaceuticals Inc.	0378-9071	00378-9071-93
Rivastigmine	Rivastigmine 13.3 mg/24h	PatchTransdermal	Mylan Pharmaceuticals Inc.	0378-9072	00378-9072-93

All 17 Rivastigmine NDCs

Other NDCs under ANDA 206318

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206318
Product	Strength	Form · route	Labeler	Product NDC
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Northstar Rx LLC.	16714-116
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Northstar Rx LLC.	16714-117
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1196
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1197
Rivastigmine	Rivastigmine 13.3 mg/24h	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1198
Rivastigmine	Rivastigmine 4.6 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1949
Rivastigmine	Rivastigmine 9.5 mg/24h	Patch, Extended releaseTransdermal	Zydus Lifesciences Limited	70771-1950